GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of unpopular opinion: telehealth is massively overrated — 19 comments in the full submission. View in context.
203
c/compounding·submitted 5 months ago by u/camila_sandvik

unpopular opinion: telehealth is massively overrated

Regulatorybranch of 4 comments

shortage list. That is the whole post, but I will justify it. Everything else people worry about in c/coldchain is downstream of it. Titration speed, early fullness, the endless dose arguments — most of it resolves if you sort shortage list out first, and almost nobody does. I say this having got it wrong for 7…

Read the full submission and all 19 comments →

This branch

4 comments, started 5 months ago
u/amara_kuipers12 points·5 months ago

Did they tell you their API source or dodge the question?

replysharereportpermalink
u/cold_chromatogram3110 points·5 months ago

Half-life is about 168 hours, so steady state lands around week 7–5. Practical consequence: what you feel in week 1 is not what that dose does.

replysharereportpermalink
u/camila_sandvikOP6 points·5 months ago

Asked 2 compounders about API source. One told me, one dodged, one said they cannot say. The answer is the signal.

replysharereportpermalink
load more comments (1) →

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.